Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kher

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Expert Opinion on Investigational Drugs|January 5, 2002
Critical appraisal of current antithrombotic trials in patients undergoing total hip replacementA Kher
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 29, 2016
Allocation Based on Virtual Crossmatch Alone: Not Yet Ready for PrimetimeA Kher
Pathologie-Biologie|December 1, 1976
[Urokinase. Biochemical therapeutical and therapeutical data (author's transl)]A Kher
Pathologie-Biologie|December 1, 1982
[Development and dissemination of malignant tumors and hemostasis]A Kher, P Hilgard
Anesthesie, Analgesie, Reanimation|May 1, 1975
[Prophylaxis of postoperative venous thrombosis by subcutaneous heparin administered in small doses. Recent findings]F Toulemonde, A Kher
Annales De Chirurgie|February 1, 1975
[Incidence and severity of postoperative thromboembolic accidents. Assessment of the prophylactic use of low dosage heparin (author's transl)]A Kher, F Toulemonde
Annals of Medicine|February 24, 2001
Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery diseaseS Husted, A Kher
Indian Journal of Nephrology|December 15, 2015
Optimizing twice weekly dialysis-converting two-star into five-star treatment?A Kher, V Kher
Coeur Et Medecine Interne|April 1, 1979
[Theoretical bases for the use of anticoagulants and thrombolytic agents]M Samama, A Kher
La Revue Du Praticien|April 11, 1977
[Mechanisms of venous thrombosis. Therapeutic deductions on prophyloxis]M Samama, A Kher
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Expert Opinion on Investigational Drugs|January 5, 2002
Critical appraisal of current antithrombotic trials in patients undergoing total hip replacementA Kher
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 29, 2016
Allocation Based on Virtual Crossmatch Alone: Not Yet Ready for PrimetimeA Kher
Pathologie-Biologie|December 1, 1976
[Urokinase. Biochemical therapeutical and therapeutical data (author's transl)]A Kher
Pathologie-Biologie|December 1, 1982
[Development and dissemination of malignant tumors and hemostasis]A Kher, P Hilgard
Anesthesie, Analgesie, Reanimation|May 1, 1975
[Prophylaxis of postoperative venous thrombosis by subcutaneous heparin administered in small doses. Recent findings]F Toulemonde, A Kher
Annales De Chirurgie|February 1, 1975
[Incidence and severity of postoperative thromboembolic accidents. Assessment of the prophylactic use of low dosage heparin (author's transl)]A Kher, F Toulemonde
Annals of Medicine|February 24, 2001
Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery diseaseS Husted, A Kher
Indian Journal of Nephrology|December 15, 2015
Optimizing twice weekly dialysis-converting two-star into five-star treatment?A Kher, V Kher
Coeur Et Medecine Interne|April 1, 1979
[Theoretical bases for the use of anticoagulants and thrombolytic agents]M Samama, A Kher
La Revue Du Praticien|April 11, 1977
[Mechanisms of venous thrombosis. Therapeutic deductions on prophyloxis]M Samama, A Kher
Pageof 12